Aurobindo Pharma Limited (AUROPHARMA)
₹1,319.45
INR-29.35(-2.18%)
As of January 3, 2025 10:00:00 AMValuation Metrics
Market Cap
Total market value of the company's outstanding shares
₹72606.06 Cr
Enterprise Value
Total value of the company including debt and excluding cash
₹74551.79 Cr
P/E Ratio (TTM)
Price to Earnings ratio based on trailing 12 months
20.40
Forward P/E
Price to Earnings ratio based on forecasted earnings
20.07
PEG Ratio
Price/Earnings to Growth ratio
20.07
Price to Sales (TTM)
Price to Sales ratio based on trailing 12 months
2.40
Financial Metrics
Gross Margin
Gross profit as a percentage of revenue
58.01%
Operating Margin
Operating income as a percentage of revenue
15.19%
Return on Equity
Net income as a percentage of shareholders' equity
12.13%
Revenue (TTM)
Total revenue over trailing 12 months
₹30295.02 Cr+8%
EBITDA
Earnings Before Interest, Taxes, Depreciation, and Amortization
₹7092.08 Cr
EPS (TTM)
Earnings Per Share over trailing 12 months
₹61.28+8%
Balance Sheet
Total Cash
Total cash and short-term investments
₹6868.23 Cr
Total Debt
Total short-term and long-term debt
₹8427.25 Cr
Debt to Equity
Total debt as a percentage of shareholders' equity
27.29%
Stock Information
52 Week Range
Lowest and highest stock price over the past 52 weeks
₹958.5 - ₹1592
Beta
Measure of stock's volatility compared to the market
0.59
Shares Outstanding
Total number of shares issued by the company
₹58.08 Cr
Dividends & Splits
Forward Dividend Yield
Expected dividend yield based on forward dividend rate
0.50%
Trailing Dividend Yield
Dividend yield based on trailing 12 months
0.12%
Payout Ratio
Percentage of earnings paid as dividends
7.34%